Skip to content

Lecanemab in Early Alzheimer's Disease.

Randomized controlled trial · N Engl J Med · 2023. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 36449413

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Lecanemab in Early Alzheimer's Disease.

van Dyck CH, Swanson CJ, Aisen P et al.
N Engl J Med · 2023

PubMed ID
36449413
Record checked

Linked publication notices

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.